Clinical Trial Update: CARPALL: Immunotherapy with CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CD19+CD22 CAR T-cells (CARPALL) for CD19+/CD22+ acute lymphoblastic leukemia. It is currently recruiting at University College…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CARPALL CD19+CD22 CAR T-cells (CD19+CD22 CAR T-cells)

Snippet

Sponsor: University College, London | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING